Allurion stock soars on weight-loss therapy update. Stardust Power breaks ground on Oklahoma lithium refinery. OpenAI ...

The study of more than two million veterans with diabetes details GLP-1 RA use relating to 175 outcomes; without ...

The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...

When investors are paying such high price tags for a stock, expectations are high, and any kind of miss can result in a steep ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

Hi there! If you’re here, chances are you’re on a GLP-1 medication like Ozempic, Wegovy, or Mounjaro, and you’re looking ...

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

The media queen also confessed that she was reluctant to take a GLP-1 drug because she felt it was “the easy way out.” That ...

About one in eight adults in the United States has tried or currently uses a GLP-1 medication, and a quarter of those users ...

Diabetes and weight management drugs dominated game-day NFL advertising during the regular season, with TV outcomes company ...